0.9934
price down icon8.26%   -0.0966
 
loading

Finanzdaten der Artelo Biosciences Inc-Aktie (ARTL)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
3.089
- 2.379 3.812 1.195
Interest Income/Expense
0.111
- - - -
Operating Income/Loss
-3.089
- -2.379 -3.812 -1.195
Nonoperating Income/Loss
-0.031
- 0.007 0.034 0.063
Income/Loss From Continuing Operations Before Tax
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Net Income/Loss
3.14%
-3.12
-3.221 -2.372 -15.87 -1.132
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - -12.10 -
Diluted Average Shares
0.787
- 3.281 0.01 3.228
Diluted Earnings Per Share
-3.97
- -0.72 -1.17 -0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.40%
$79.77
price down icon 5.54%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
Kapitalisierung:     |  Volumen (24h):